If Congress changes hands during next year’s mid-term elections, we can expect the 340B program to be back under the spotlight with a renewed effort to place significant restrictions on the program, 340B Report Publisher and CEO Ted Slafsky writes
…SPONSORED CONTENT
If you work for an organization specializing in HIV care and/or prevention, you no doubt work incredibly hard to ensure you provide care that is patient-focused in an environment that is affirming and welcoming. I can imagine on your clinic’s walls there are informational posters about the importance of preventative
…
Q: Where did you grow up?
I grew up in Winter Garden, FL just outside of Orlando where I still reside. My kids go to the same high school my wife and I attended.
Q: Where did you go to college/graduate school?
I received my pharmacy degree from the University of Georgia. My MBA was through Crummer School
…
A federal district judge in New Jersey has denied drug manufacturer Sanofi’s emergency motion for a stay against 340B administrative dispute resolution (ADR) proceedings—in part because she said she will hand down her decision in Sanofi’s 340B contract pharmacy lawsuit
…
The U.S. Health and Human Services Department (HHS) is poised to rescind Trump administration regulations that have added to doubt about the authority of HHS guidance documents, including those for the 340B program.
During the Trump administration, the U.S Health
…
U.S. District Judge Dabney Friedrich all but told the federal government during a court hearing in Washington, D.C., on Tuesday she rejects its basic argument that the plain text of the 340B statute requires drug manufacturers to honor 340B purchases
…
The ban on 340B discounts on orphan drugs for rural and free-standing cancer hospitals may give drug companies a powerful incentive “to seek orphan designation for drugs approved to treat common diseases or conditions,” the U.S. Health and Human Services
…
The 340B Coalition announced Tuesday that its annual winter conference will be held in person Jan. 31 to Feb. 2, 2022, in San Diego. Its last, pre-pandemic in-person conference was Feb. 10-12, 2020, also in San Diego.
Apexus, the 340B
…*Sign up for news summaries and alerts from 340B Report
